Skip to content

A study to evaluate various methods to detect resistance of gram negative clinical isolates towards the polymyxin drug Colistin and compare the methods with the gold standard method of detection of colistin resistance.

Evaluation of detection methods of Colistin resistance in clinical isolates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/037827
Enrollment
150
Registered
2021-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere Health Condition 2: C159- Malignant neoplasm of esophagus, unspecified Health Condition 3: G01- Meningitis in bacterial diseases classified elsewhere Health Condition 4: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified Health Condition 5: L768- Other intraoperative and postprocedural complications of skin and su

Interventions

None listed

Sponsors

GB PANT HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL FIRST ISOLATES OF KLEBSIELLA SPECIES AND ESCHERICHIA COLI FROM CLINICAL SAMPLES OF ADMITTED PATIENTS OF GIPMER NEW DELHI

Exclusion criteria

Exclusion criteria: GRAM POSITIVE BACTERIAL ISOLATES FROM SAMPLES BACTERIALISOLATES HAVING INTRINSIC RESISTANCE TO COLISTIN

Design outcomes

Primary

MeasureTime frame
EVALUATION OF VARIOUS METHODS OF DETECTION OF COLISTIN REISTANCE AND STANDARDIZING TESTING METHODS TO FORMULATE A PROPER ANTIBIOTIC POLICY IN THE HOSPITALTimepoint: EVALUATION OF VARIOUS METHODS OF DETECTION OF COLISTIN REISTANCE AT THE END OF ONE YEAR

Secondary

MeasureTime frame
RISK FACTOR ANALYSIS FOR DEVELOPMENT OF COLISTIN RESISTANCE AMONG HOSPITALIZED PATIENTSTimepoint: RISK FACTORS WHICH LEAD TO COLISTIN RESISTANCE

Countries

India

Contacts

Public ContactTANVI AGGRAWAL

GB PANT HOSPITAL

aggrawaltanvi@gmail.com9899180286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026